Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

Medicine, Oncology, Pharmacology +10

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Melody Cobleigh, Charles L. Vogel, Debu Tripathy et al. · Journal of Clinical Oncology · 1999 · 2.8K citations

Medicine, Oncology, Pharmacology +17

Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells.

Harry T. Haigler, Frederick R. Maxfield, Mark C. Willingham et al. · Journal of Biological Chemistry · 1980 · 794 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15

Evaluation of Monoclonal Humanized Anti-HER2 Antibody, Trastuzumab, in Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma With Overexpression of HER2: A Phase II Trial of the Gynecologic Oncology Group

Michael A. Bookman, Kathleen M. Darcy, Daniel L. Clarke‐Pearson et al. · Journal of Clinical Oncology · 2003 · 613 citations

Medicine, Gynecology, Oncology +17

Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer

Caroline Witton, Jonathan R. Reeves, James J. Going et al. · The Journal of Pathology · 2003 · 592 citations

Medicine, Molecular Biology, Oncology +14